Root Admin Guide Posted November 12, 2020 Root Admin Report Share Posted November 12, 2020 Zilxi is the first monocycline topical foam to be approve for rosacea by the FDA and is now available. Now available announced by Vyne Therapeutics. Ask your dermatologist. Post your experience in this thread. Find the reply button. "The Company also announced that the annual list price of ZILXI will be $485 per 30-gram canister, in parity with the wholesale price of AMZEEQ® (minocycline) topical foam, 4%, the Company's topical minocycline indicated for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris in adults and pediatric patients 9 years of age and older." PR Newswire Association LLC. All Rights Reserved. A Cision company We have been following minocycline topicals for rosacea for some time now. For more information. HIGHLIGHTS OF PRESCRIBING INFORMATION zilxiPL.pdf For more information on the Zilxi savings card Zilxi is a minocycline topical foam that has been going through clinical trials for some time now. It has been announced recently as FDA approved for rosacea (see fifth post in this thread). Minocycline, a tetracycline drug, has been shown to be just as effective as doxycycline for rosacea. If you are using Zilxi please find the reply button and post your experience using this new treatment for rosacea. Reply to this Topic There is a reply to this topic button somewhere on the device you are reading this post. Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now